Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 164 participants.
Also called NCT01275092
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 164 participants
- Sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
- Registry
-
NCT01275092
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Colombia
- Registry status
- Completed
Technical summary
Registry record NCT01275092. Allocation not applicable; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2013-08-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
- Acronym
- PRECISE
- Condition
- Coronary Artery Disease
- Condition
- Coronary Disease
- Condition
- Myocardial Ischemia
- Condition
- Heart Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Arteriosclerosis
- Condition
- Arterial Occlusive Diseases
- Condition
- Vascular Diseases
- Intervention (Device)
- CorPath robotic-assisted PCI (percutaneous coronary intervention)
- Lead sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
Record details
- Record id
cardio:ct-nct01275092- Content hash
5f454759fad2da923ef2c86ee02635bdeb98ffff5c662663befdd418946aebe9